Merck signs MoU with Indian CDMO; Scorpius delays public offering
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
Merck and Indian CDMO Aragen have …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.